<DOC>
	<DOC>NCT01574313</DOC>
	<brief_summary>Stellate ganglion block (SGB) has been the alternative treatment of Meniere's disease for years. However, objective evidence of the effect of SGB was still lack. The investigators conducted a randomized controlled study to examine the immediate effects of SGB in SP/AP of electrocochleography (ECoG).</brief_summary>
	<brief_title>Effect of Stellate Ganglion Block on Meniere's Disease</brief_title>
	<detailed_description>Ten patients were randomly assigned to receive stellate ganglion block. These ten patients made up the experimental group. Another ten patients in the control group were assigned to receiving one dosage of oral medications: 0.25mg of erispan@ (fludiazine) , 25mg cephadol@ (diphenidol), and 200mg kentons@ (tocopherol nicotinate).</detailed_description>
	<mesh_term>Vertigo</mesh_term>
	<mesh_term>Dizziness</mesh_term>
	<mesh_term>Ganglion Cysts</mesh_term>
	<mesh_term>Synovial Cyst</mesh_term>
	<mesh_term>Meniere Disease</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<mesh_term>Diphenidol</mesh_term>
	<criteria>patients diagnosed with unilateral Meniere's disease, according to the criteria of the American Academy of OtolaryngologyHead and Neck Surgery, AAOHNS (1995) patients with coagulopathy, arrhythmia, myocardial ischemia, glaucoma, pregnant, chronic otitis media or externa, and past history of middle or inner ear surgery were excluded.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>stellate ganglion block.</keyword>
	<keyword>Meniere's disease.</keyword>
	<keyword>electrocochleography.</keyword>
	<keyword>vertigo.</keyword>
	<keyword>hearing impairment.</keyword>
</DOC>